Some of the most popular blood pressure medications in the United States may cause cancer, according to a new analysis of clinical trial data. But experts are quick to point out the results of the study are not definitive and that consumers should not take any harsh measures before first discussing the risk and benefits of taking the medication with their health care professional. The drugs in question include Micardis from Boehringer Ingelheim, Diovan from Novartis, Benicar from Daiichi Sankyo, and Merck’s generic Cozaar. Just last week the Food and Drug Administration (FDA) announced it was looking into Benicar (olmesrtan) ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.